Associated Press AP

Janet Jackson, Radiohead, Def Leppard to Join Rock & Roll Hall of Fame

Janet Jackson is one of the seven acts joining the Rock & Roll Hall of Fame next year.
Janet Jackson is one of the seven acts joining the Rock & Roll Hall of Fame next year. Photo: Getty Images

The Rock & Roll Hall of Fame named Radiohead, Janet Jackson, Def Leppard, the Cure, Roxy Music, Stevie Nicks and the Zombies to its class of 2019, seven acts that will join the Cleveland institution at its 34th annual ceremony in March.

The latest inductees nod more to stars from the 1980s and 1990s than in years past. Radiohead popularized experimental rock in the 2000s. Janet Jackson mixed pop and R&B with commercial success in the ’80s and ’90s, while Def Leppard gave hard rock a radio-friendly pop sheen. The Cure offered gloomy post-punk music, helping make alternative rock mainstream. Roxy Music (including Bryan Ferry and Brian Eno) and Stevie Nicks, a solo artist and member of Fleetwood Mac, are long-time cult favorites. In the 1960s, the Zombies, part of the British Invasion, tested the boundaries of pop and rock.

The previous inductees, the class of 2018, were more representative of popular music’s distant past, with artists like Nina Simone and Sister Rosetta Tharpe inducted.

Radiohead is joining Ms. Jackson, the Cure, Def Leppard, Roxy Music, Stevie Nicks and the Zombies in the Rock & Roll Hall of Fame’s class of 2019.
Radiohead is joining Ms. Jackson, the Cure, Def Leppard, Roxy Music, Stevie Nicks and the Zombies in the Rock & Roll Hall of Fame’s class of 2019. Photo: Agence France-Presse/Getty Images

Three of the 2019 inductees are first-time nominees: Def Leppard, Roxy Music and Ms. Nicks. (Fleetwood Mac entered the Rock Hall in 1998.) Radiohead and the Cure will join on their second tries, while it is a third nomination for Ms. Jackson and a fourth for the Zombies, which has been eligible since 1989.

Several acts that have been nominated many times didn’t get in this time, including Rufus featuring Chaka Khan, MC5, LL Cool J and Kraftwerk. Other nominees that didn’t make the cut include rap-rock group Rage Against the Machine and first-time nominees Todd Rundgren, Devo and John Prine.

An international voting body of more than 1,000 music executives, artists and past winners weighed in on this year’s nominees. According to the Rock Hall’s rules, artists are eligible for nomination 25 years after their first commercial recording, which for the newly announced class is 1993.

The Rock Hall also allows the public to vote on a “fans’ ballot” whose five winners gain an edge in the overall voting. This year, Def Leppard led the fan vote, with Ms. Nicks, the Zombies and the Cure also among the winners and inductees. The only fan-vote winner who didn’t get inducted was Mr. Rundgren.

Write to Neil Shah at neil.shah@wsj.com

Rami Malek Had A Crazy Exercise And Diet Routine For Bohemian Rhapsody

While Bohemian Rhapsody received mixed reviews as a film, most have praised Rami Malek’s performance for the way he seemingly transformed into Queen frontman Freddie Mercury. The actor has spoken at length about the way he watched a lot of Mercury in an attempt to learn how to move and how to speak like the eccentric performer, but it turns out that becoming Freddie Mercury also included a serious diet and exercise routine in order to both physically look like the man, as well as have the ability to perform in the way that he did. According to Malek…

Getting in the right physical shape for a role is important. It’s frequently a key part of action movies, but in the case of Bohemian Rhapsody, Rami Malek needed to be in shape so that he could perform like Freddie Mercury. The singer was an energetic and enthusiastic performance, and Malek had to be able to look the same way, without wearing himself out.

In addition, Malek tells The Wrap that he had to shift between adding muscle and dropping weight quickly, as he shifted between filming scenes of a young scrawny Freddie and the larger, more in shape Queen version of the man.

Shifting between heavy workouts and crash diets certainly doesn’t seem like fun and Rami Malek confirms this. Being a lead actor in a major Hollywood movie is probably a lot of fun most of the time. And sometimes it sounds like it completely sucks. Crash diets aren’t healthy and nobody recommends that people try them, but when you’re under the constraints of a multimillion dollar movie schedule, there’s little else that can be done.

Ultimately, as Rami Malek says, the goal wasn’t so much muscle as it was energy. Bohemian Rhapsody culminates in an epic finale which recreates the band’s famous 1985 Live Aid performance almost in its entirety. Malek had also confirmed that some takes were done as a single long performance, which meant Malek had to be able to put on a concert without wearing out. He did succeed, as the Live Aid sequence is the highlight of the movie.

M. Night Shyamalan Reveals Glass Was Originally Going To Be Way Longer

M. Night Shyamalan’s upcoming movie Glass is a strange beast since it’s technically a direct sequel to two different movies. Not only is it finally reuniting us with David Dunn and Elijah Price nearly 20 years after Unbreakable, it’s also following after the events of Split. With so much mythology to work with, Shyamalan acknowledged that it initially looked like Glass was going to be a tale stretching over three hours. The director recalled:

Because Unbreakable and Split are set in the same world, it’s understandable that M. Night Shyamalan wanted to dedicate plenty of time to ensure that fans of one or both of those movies would be properly caught up. Plus, one also has to account for people checking out Glass who haven’t necessarily seen Unbreakable or Split. Still, it’s rare that movies longer than three hours are released, so as Shyamalan mentioned, eventually there came a point where he started to tighten Glass up. Now the movie is a little over two hours, which is a more digestible runtime for the average moviegoer.

During his interview with Digital Spy, M. Night Shyamalan all mentioned that there’s no need for Glass to “rehash” either of its predecessors, pointing to a scene in the Glass trailers where Patricia, one of Kevin Wendell Crumb’s many alternate personalities, is speaking with a group of cheerleaders she’s kidnapped. Shyamalan explained:

While it’s fine for a sequel to remind audiences of certain events that happened in preceding movies, it can’t come at the expense of the story that’s being told now. That’s not to say that M. Night Shyamalan wasn’t worried about Glass appealing to moviegoers who aren’t familiar with Unbreakable and/or Split, but he realized that Glass needed to stand on its own, even going so far as to pitch Glass to Disney and Universal as if it were a standalone movie.

As the final chapter of the Eastrail 117 trilogy, Glass will see Bruce Willis’ David Dunn, a.k.a. The Overseer, pursuing James McAvoy’s Kevin Wendell Crumb, whose most dangerous alternate personality, The Beast, has allied itself with Samuel L. Jackson’s Elijah Price, a.k.a. Mr. Glass. Glass is also bringing back Anya Taylor-Joy, Spencer Treat Clark and Carlene Woodard as Casey Cooke, Joseph Dunn and Mrs. Price, respectively, while Sarah Paulson will appear as Dr. Ellie Staple, a psychiatrist who specializes in treating patients who believe they’re superheroes.

Glass opens in theaters on January 18, 2019. If you’re interested in other movies that are coming out next year, browse through our 2019 release schedule.

Do You Need a Fertility Test—Even If You’re Not Trying to Get Pregnant?

My feet in stirrups, I stared at the eerie black-and-white images projected on the screen in front of me, as Hailee Steinfeld’s “Love Myself” bumped energetically in the background. My ovaries, the squishy bean-shaped blobs on the screen, bounced in and out of shadows as my gynecologist shifted the ultrasound probe, searching for the follicles that produce eggs.

This was not your typical ob-gyn exam, to say the least. I’m not trying to get pregnant—quite the opposite, actually—but I paid a visit to Trellis, a new “fertility studio” and egg-freezing clinic in New York City, to learn just how fertile I am now, and will be in the years to come. With an in-house juice bar and a quote from Michelle Obama (“It’s up to each of us to invent our own future”) displayed prominently in the well-lit lounge, Trellis is one of several new startups launched in the past two years garnering attention and investor dollars for adding fertility to the list of health stats you can easily track.

The idea behind making fertility testing cheap, convenient, and trendy, stems in part from data: Women are increasingly putting off having children—for the first time, women in their thirties are now having more babies than women in their twenties, according to the CDC. But because fertility naturally starts to decline in your 30s, these companies assert information is power. “We help you understand what’s going on in your own body so you can use that information to make the decisions that are right for you,” says Afton Vechery, co-founder of Modern Fertility, an at-home fertility testing service launched in summer of 2017. Armed with your fertility stats, the idea is that you can eliminate (or at least reduce) anxiety about putting off baby-making, adjust your timeline if your proactive tests reveal any red flags, or make a more informed decision about egg freezing.

But after my procedure, I was skeptical. Is this just millennial marketing—complete with an Instagram-worthy reception area, socially-conscious brand mantras (“empowered egg freezing”), pink take-home brochures, and sleek apps—at its best?

Marketing Fertility

If you’re having trouble getting pregnant, a trip to any traditional fertility clinic will generally follow a few key steps: a look at your medical history, an ultrasound to examine your ovaries, a blood test to measure key hormones tied to egg production. No one test can tell you with 100 percent certainty if or when you’ll be able to get pregnant, but for now, the combined results of these tests are the closest you can get to a crystal ball.

The problem these startups—all led by women—have with that approach? It comes too late. Many ob-gyns or specialists won’t run these tests unless a woman is already having issues, which means the game may already be decided, or the options for action limited.

Piraye Yurttas Beim, who has a Ph.D. in molecular biology, first went to her doctor for a fertility assessment at 32. She was told, based on her fertility hormone tests, that her chances of getting pregnant using her own eggs was less than one percent. “I felt like, wait a minute, I did all the right things,” she says. “I went to my ob-gyn every year for my annual screens. Why wasn’t I screened for [fertility]? Why wasn’t I given a heads up that this was a possibility? Why was this sprung on me when it was effectively too late?” As a scientist and founder of Celmatix, a company that tests fertility-related genetic markers to help predict a woman’s baby-making odds, Beim knew that hormone levels don’t always tell the whole story. The proof? She went on to conceive her three kids naturally.

Still, hormone tests can be a starting point to getting insight into your fertility potential, which is why startups like Modern Fertility and Future Family analyze the same exact hormones traditional clinics do. This gives doctors an idea of your egg quantity, aka your “ovarian reserve” and can help a fertility specialist assess how many eggs you likely have in the bank. (Trellis operates more like a traditional fertility clinic that’s been given a chic makeover—they perform blood tests and ultrasounds, like the one I had, conducted by doctors specializing in reproductive medicine at their NYC clinic. From there, a “fertility coach” can walk you through the company’s egg freezing packages and “fertility wellness” plans.)

The science behind these tests isn’t new. But these founders hope streamlining the process of getting them will help women move from being reactive to proactive about fertility. Now, you can order a hormone test online (you can either prick your finger at-home, or get an order to have blood taken at a local lab) for under $200. Old school fertility testing would require jumping through hoops to find your way to a fertility specialist, where you may be socked with a hefty bill—potentially reaching into the thousands—that may not be covered by insurance.

Getting Answers Without Fear

Conversations about fertility have long felt like scare tactics, pressuring women to have kids ASAP or shell out cash to freeze their eggs before time runs out. Past awareness campaigns even included an upside down baby bottle as a rapidly dwindling hourglass. The fear-mongering around fertility isn’t just uncool, evidence suggests it can be costly—only 6 percent of women who froze their eggs went on to actually use them, in one small 2017 study. (Most women in the study who were pregnant at some point, conceived naturally.)

The modern conversation, as I experienced, has gotten a major course correction. These days doctors really, really don’t want the results from these tests to cause any panic. “It’s incredibly complicated,” says Paula Brady, M.D., a fertility specialist the Columbia University Fertility Center. “We can’t take one value and say, ‘This is great, don’t worry,’ or ‘This is bad, you should be worried.’”

My blood tests (one from Modern Fertility and another from Trellis) and ultrasound revealed that, while I’m still technically within the “normal” range for a woman in her late 20s, I have a less than stellar ovarian reserve. My AMH level, perhaps the best indicator of how many eggs I have, is “lower than expected for [my] age,” Trellis found.

My first reaction: Holy shit. Do I need to freeze my eggs?

It’s surprisingly hard not to panic about these results. But as I made more calls, almost every expert I spoke with stressed that my ovaries’ meh report card was no reason to freak out. “The low edge of normal is still in the normal range,” assured Nataki Douglas, M.D., director of translational research for the department of obstetrics, gynecology and women’s health at Rutgers University and chair of the medical advisory board at Modern Fertility. A below average test result, in other words, doesn’t mean you should rush to put your eggs on ice.

The Fertility Prediction Blind Spot

Not only is the science of predicting fertility imperfect and complex, it also has a major blind spot: Even the techiest and trendiest fertility assessments look only at the quantity of eggs you have when evidence suggests the quality of your eggs is equally important. Last year a team of reproductive researchers led by the University of North Carolina Chapel Hill found women with signs of “diminished ovarian reserve” were just as successful at getting pregnant as women with a normal reserve. Basically, an underwhelming ovarian reserve result might mean something about your ability to get pregnant in five years—or it might not. (The best predictor of egg quality doctors have is your age.)

These new companies believe the services they provide could add another layer of data to your family planing calculations. Testing early, they suggest, means you can track your fertility stats over time—one AMH test might not tell you much on its own but a drastic drop in the hormone year-over-year is a more reliable red flag, Dr. Douglas says. “The key is to have the information so that you’re empowered to make decisions and have informed discussions with the right people,” she adds.

Still, experts don’t recommend all women start tracking AMH levels with the same rigor as you might track your steps or your sleep. “I always say check a value if you would do something with the result,” says Dr. Brady. If your mom went through early menopause, for example, getting your hormone levels tested could give you a little more insight about having kids earlier or freezing your eggs. Or if your period is irregular, a fertility assessment might help shed light on conditions like PCOS that could impact your baby-making plans. But if seeing ambiguous below-average hormone levels will only make you stress, Dr. Brady says it might be best to pass.

After two hormone tests, one ultrasound, and nearly a dozen interviews with reproductive experts, I still don’t know if I can confidently put off pregnancy for another five years or whether I should sign up for egg freezing at Trellis (estimated cost: $12,850 plus $600 per year in egg storage fees). I have my results, but I don’t exactly have answers. “It would be awesome if we could have a single blood test or an ultrasound that could really lay out your future,” says Alan Penzias, M.D., chair of the American Society for Reproductive Medicine’s Practice Committee. “But right now, I don’t think we’re quite there.”

I’ve wrestled a lot with how I feel about that. Unlike years ago when that baby-bottle-as-hourglass campaign got major backlash, women today know more than ever about our bodies. We track our steps, our sleep cycles, our periods right on our phones. We’re fluent in data about our bodies, ourselves. This whole panoply of information about our bodies helps us make more “empowered” decisions—so why wouldn’t the same be true about fertility data? Now, rather than remaining in the dark about what my ovaries are up to, I’m armed with baseline information that I can use to start a conversation with my gynecologist about the choices I’ll be making for my body over the next five, even ten, years.

Testing early means I don’t feel like I’m at the mercy of my biology—I feel like I’m in the driver’s seat.

Marvel Really Wanted A Female Director For Black Widow

The Marvel Cinematic Universe is in a fascinating place right now, as the studio and Disney are keeping their cards extremely close to the chest. While this helps keep the contents of Avengers: Endgame a complete mystery, it’s also caused some anxiety amongst the fandom, which is used to Marvel’s extensive release schedules. One of the few projects to be announced after Phase Three is the Black Widow movie, which will finally give Scarlett Johansson’s signature character a chance to lead her own blockbuster.

The Black Widow movie is set to be directed by Cate Shortland, but she obviously wasn’t the only one approached to helm Natasha Romanoff’s highly anticipated solo movie. Argentinian director Lucrecia Martel recently revealed she was also approached to helm Black Widow’s solo flick, and it seems that Marvel Studios made it a point to hire a female filmmaker for the project. As she told it,

Not only is Black Widow finally getting her moment in the spotlight in Phase Four, but it seems the studio was very concerned with having a female director helm the project. Mostly so that the person at the head of the project can fully develop the title character.

Over the past few years, there has been a ton of conversation in the film industry about inclusivity. In the wake of the #OscarsSoWhite and #TimesUp movements, the call for diversity both in front and behind of the camera has been deafening. The MCU has been allowing people of color and women to take larger roles, and the Black Widow movie will finally give Scarlett Johansson’s character the chance to take center stage.

In her same appearance at the Mumbai Film Festival (via Daily Pioneer), Lucrecia Martel described how her conversations with Marvel Studios went. And while the MCU made a conscious effort to hire a female director, it seems the studio didn’t want Martel to handle things like action sequences. She elaborated, saying:

Well, that was honest. Lucrecia Martel has certain things she does and doesn’t like about the Marvel Cinematic Universe, and property’s music seems to be a particular point of contention. That, and the fact that the studio reportedly didn’t want her to handle things like action sequences.

CinemaBlend will keep you updated on all things Black Widow, as the movie’s details finally become public. You can catch the fan favorite character appear in Avengers: Endgame on April 26, 2019. In the meantime, check out our2019 release list to plan your trips to the movies in the New Year.

Once Upon A Deadpool Promotion Has Offended Some Members Of The Mormon Church

The new Deadpool may be more family-friendly, but that doesn’t mean that he has become entirely inoffensive. A petition is online which has asked that one of the posters for Once Upon a Deadpool be pulled, as it constitutes religious discrimination. The poster sees Deadpool at the center of the image and dressed all in white. He’s surrounded by characters from the film who look like angels. Check it out below.

The problem, according to the Change.org petition, is that the image for the Once Upon a Deadpool poster is based on a sacred picture to the Church of Latter-Day Saints, entitled The Second Coming. Deadpool has taken the place of Jesus Christ in the image, which the petition claims mocks the church, and the petition asks that the film stop using this poster and find something different to promote the PG-13 version of Deadpool 2.

Unfortunately, as written, the new petition isn’t going to carry much weight, as it’s directed to the wrong place. Change.org petitions need to be sent “to” a person or other entity and clearly, the person who created this one only did minimal research on the Deadpool franchise. This petition is being directed at Tim Miller, who was the director of the original Deadpool but left Deadpool 2 early in production, to be replaced by David Leitch.

Errors in attribution notwithstanding, the petition does have some support, as it has received over 36,000 signatures as of this writing. It’s not the massively overwhelming support that many movie based petitions have received, but it’s certainly a significant number of people.

Of course, while Once Upon a Deadpool might be a PG-13 version of the movie, the film is still a Deadpool movie. It’s not like everybody involved didn’t know what they were doing when they chose that particular religious image as the basis for the poster. Is it potentially offensive? Sure it is, but that was obviously the point. There were even rumors before the release of Deadpool 2 that the film was going to be subtitled The Second Coming, so it’s possible the studio has had this poster idea kicking around for a while, and just decided that it made sense to use it for the Christmas time release of Once Upon a Deadpool.

Of course, due to the fact that Once Upon a Deadpool has already been released in theaters, it’s unlikely that this petition will have any effect on anything. It could convince the studio to not use the image as the cover for the eventual Blu-ray release, but, honestly, the other Once Upon a Deadpool poster, which features Fred Savage and Deadpool astride Rudolph the Red-Nosed Reindeer, is a better image for that anyway. Any official response from the filmmakers or the studio seems unlikely, but we’ll have to wait and see.

U by Kotex Tampons Have Been Recalled—Here’s What You Need to Know

Kimberly-Clark, the company behind Kotex tampons and pads, just issued a major recall: they’re pulling U by Kotex Sleek Tampons off shelves after reports that the tampons can unravel inside your body.

The Kotex recall, announced this week, comes after reports that U by Kotex tampons (the regular absorbency variety) were unraveling or breaking apart when women tried to remove them. Some women actually had to seek medical attention to remove the bits of the tampon from their bodies, according to a statement released by the company.

The product defect isn’t just uncomfortable-sounding, it could cause serious health risks. Per the Kimberly-Clark’s statement, there have been a “small number” of reports of infections (i.e. yeast infections, bladder infections and bacterial vaginosis), irritation (such as itching and swelling) and “localized vaginal injury” (think: pain and bleeding).

Tampons have been under increased scrutiny by scientists and lawmakers in recent years as researchers begin to look into how the chemicals used to make them—bleach, pesticides, fragrances—might be affecting your vaginal health. (So far, there’s no definitive evidence that the impact of the trace amounts of these chemicals is enough to really do damage in humans, but considering the fact that the average woman uses nearly 17,000 pads and tampons in her life, it’s enough to prompt some women to go the menstrual cup route instead.)

So, how do you know if your tampons are part of the Kotex recall? The defective batch was sold between October 17, 2016 and October 23, 2018, so if you bought any U by Kotex Sleek tampons during that time frame, you can check the lot number on the box—look for the nine-digit number on the bottom of the box and enter it into Kotex’s recall database—to see if your stash is part of the recall.

“Any consumer with the impacted U by Kotex Sleek Tampons, Regular Absorbency, in their possession should stop using the product immediately,” according to a statement released by the FDA. And if you’re experiencing any irritation, pain, or symptoms that are out of the norm after using a tampon—or if it starts to break apart as you remove it—talk to a doctor ASAP.

Taylor Swift’s Reputation Stadium Tour Is Coming To Netflix Very Soon

Miss out on Taylor Swift‘s Reputation stadium tour? Or maybe you went but sat so high up that you could barely see what was happening onstage and had to watch everything on the massive screens? Don’t worry — she’s got you covered.

The singer’s ending 2018 by giving something back to her fans: namely a chance to experience the globetrotting, 53-date Reputation tour with an intimate, professionally shot, immersive concert film, coming to Netflix on (fittingly) New Year’s Eve.

Swift announced the new movie on social media on Thursday morning (December 13), which also happens to be her 29th birthday. “You made this tour so insanely fun for all of us on stage, and I’m really excited that we will have this memento of the memories we all made together this year,” she wrote on Instagram.

The clip she teased features plenty of sweeping, crane-aided shots of her Reputation live set, from the quiet piano numbers to the storytelling guitar tunes to the all-out, high-concept dance numbers. Swift’s pals and tour supporting acts Camila Cabello and Charli XCX made a quick appearance alongside her onstage too, as they tended to do.

It’ll be a strong way to end the year from Swift, who’s been keeping things low-key since wrapped the Reputation tour in November. Last week, she joined Hayley Kiyoko onstage in New York City for a surprise team-up on “Delicate,” and earlier this week, she shouted out young songwriter Maggie Rogers for a dynamite cover of her own “Tim McGraw,” calling it “heavenly.”

Oh yeah, and she also left Big Machine, her record label of the past 15 years, to sign with Republic and to own all her own master recordings going forward. That’s a pretty big deal, too.

Catch Taylor Swift Reputation Stadium Tour premiering on Netflix at 12:01 PT on December 31.

John Mayer Is Reportedly ‘Very Into’ Kourtney Kardashian, and We’ve Reached Peak 2018

In news literally no one saw coming, John Mayer is reportedly harboring a little crush for Kourtney Kardashian.

The report comes from Us Weekly, which claims Mayer was seen chatting with Kardashian at GQ‘s Men of the Year party on Thursday, December 6. “[He] seemed very into her,” an eyewitness tells Us Weekly. Mayer reportedly even told Kardashian that running into her was “sweet serendipity” and they should “meet up again soon.” (Catch Mayer’s new single “Sweet Serendipity” in early 2019, inspired form this event. Just kidding.)

So many thoughts are running through my mind. Is Mayer a fan of Keeping Up With the Kardashians? Does he know about the time Kourtney laughed at Kim for crying on vacation? Or when she told Kim that “people were dying” after she lost her diamond earrings in the ocean? Surely he knows about “Nancy,” right?

Unfortunately, though, this crush might be one-sided. A source tells Us Weekly that Mayer isn’t Kardashian’s “type at all.” So, it looks like you won’t have to prepare yourself for this out-of-the-box pairing. (Which is a bit of a relief, TBH. 2018 has been the year for shocking new celebrity couples. Please see: Priyanka Chopra and Nick Jonas, Ariana Grande and Pete Davidson, and Channing Tatum and Jessie J.)

If John and Kourtney aren’t dating, maybe this clears up room in his schedule for him to help Kim with her music career. Remember her song “Jam?” And the accompanying music video? John is the only person qualified to help her come up with a sequel to that masterpiece. The Billboard charts are waiting, you two.

Related Stories:

Katy Perry Just Ranked Exes Diplo, Orlando Bloom, and John Mayer in Bed

Kourtney Kardashian Is Being Mom-Shamed on Instagram for Her Son’s Long Hair

Kourtney Kardashian Cleverly Shut Down Thanksgiving Trolls Who Think She’s Pregnant

Mustela Stelatopia Emollient Cream is the Best Drugstore Moisturizer for Dry Winter Skin

In the summer, my face is an oil slick—or as kinder souls have put it, “so glowy!” Then, one day, fall turns to winter and severe dry patches begin appearing beneath my eyes and around my nose. It happens every year, like clockwork.

In the past, this signaled a mad scramble to find any solution that actually worked. Back before I knew better, I tried the multi-pronged layering approach, sandwiching serums between face mists and ointments and salves while muttering under my breath about the complexities of my skin’s love language. This fixed the problem to some extent, but it also meant going to bed with my face marinating under an inch of greasy product (woe to my pillowcases if I happen to turn over in my sleep). It was also totally out of the question for my morning routine—if a tiny gust of wind blew so much as a stray leaf my way, I was done for.

It took a few years of trial and error, but eventually, I discovered a far easier, smarter option. And I will happily reveal it to you now because it only requires that you make a trip to your nearest Target (where you’re probably already planning to go for snacks, holiday decorations, and more things than you can carry anyway). Once you enter, walk toward the skin care aisle and then keep on moving; what you want isn’t located here. Instead, set your sights on the baby section, where you’ll find a few shelves stocked with my holy grail French skin care brand, Mustela.

Mustela is a line geared toward those between the stages of newborn and toddler; the products are all tested on a patented baby epidermal model (please do not ask me what this means, but I know that no actual baby faces are involved in the process) and evaluated by a third-party toxicologist to ensure safety. I’m not exactly in that target audience, but the products work fine on adults as well—just consider them a great choice for sensitive skin. Everything I’ve tried from them has been incredibly effective, even when my face is at its most dry and inflamed. The Hydra-Stick with Cold Cream is my faithful plane companion—a creamy, comforting block that pulls double duty as lip balm and moisturizer. The Cleansing Wipes never leave my face feeling stripped or overly dry. And the tiniest bit of 1 2 3 Vitamin Barrier Cream under my nose saves me every allergy season, when my skin becomes chapped and red otherwise.

The one I go back to again and again, though, is the giant tube of Stelatopia cream, which I slather on generously. (For $23, I can afford to apply liberally.) I dispense a pea-sized amount in my palm morning and night and pat it into my skin. Sometimes I combine it with a serum if I’m in need of a brightening or firming boost, but often I wear it alone, content to let it work its magic without any extra frills.

While the formula doesn’t feature the kind of plush, rich texture I’m used to from ultra-nourishing creams, it more than makes up for the lack of sensorial experience with its restorative properties. The lotion comes out fluid and light, sinking into my skin almost instantly and leaving no residue behind. As soon as it meets a dry patch, I can almost feel my face sighing in relief. There are formulas that hydrate and formulas that heal—this does both, which makes sense as it’s designed for eczema-prone complexions. This is thanks to avocado perseose (a new-gen biomimetic—essentially, a patented ingredient that mimics the skin’s barrier function) and sunflower oil distillate, the two key actives in the ingredients list.

“They work together to reinforce the skin barrier, maintain moisture, and minimize water loss,” says FAAD Associate Professor of Pediatric Dermatology, Latanya T. Benjamin, MD. To break that down further: Your skin barrier keeps pollutants out and the good stuff in. When it’s compromised (whether by the elements or by other culprits like too much exfoliation), your skin easily becomes dry and irritated. Ceramides are a lipid that form this barrier, so naturally, you want more of them. Similarly, sunflower oil distillate also helps replenish your lipids and reduce inflammation at the same time. Together, they do everything I was looking for in those 8 layers of product I formerly buried myself in. If I could add these two ingredients to everything I use between November and April, I would. Then again, I really only need this single tube.

Mustela Stelatopia Emollient Cream, $23, target.com

Related Stories:
All the Natural Skin Care Products I Use to Fight Dry Skin in the Winter
6 Annoying Winter Skin Issues—Solved
The No-Frills Face Cream That Tackles the Toughest Dry Spots